Abstract
The aims of this study were to assess whether sodium cromoglycat (SCG) was an effective prophylaxis against both upper and lowr respiratory tract signs and to determine factors which affected the site and magnitude of the response to SCG. Sixteen children born prematurely were entered into a randomised placebocontrolled trial at 15 months of age (range 4–31 months). The patients received, in random order, either 3 weeks' treatment with SCG (5 mg) or placebo, both given four times a day by inhalation via a spacer device. Parents were asked to record the occurrence and severity of their child's upper respiratory tract signs; sneezing and runny nose and lower respiratory tract signs; day and night time cough and wheeze. During the active compared to the placebo period there was an overall reduction of 47% and 53% in upper and lower respiratory tract signs, respectively. The magnitude of response to SCG as assessed by either the change in upper or lower respiratory tract signs was not significantly related to the patient's gestational or postnatal age, the occurrence of neonatal chronic lung disease, family history of atopy or the order in which the therapy was administered. We conclude that inhaled SCG may be a useful prophylaxis for both upper and lower respiratory tract signs for children born prematurely and less than 3 years of age.
Similar content being viewed by others
Abbreviations
- SCG:
-
sodium cromoglycate
References
Geller-Bernstein C, Levin S (1982) Nebulised sodium cromoglycate in the treatment of wheezy bronchitis in infants and young children. Respiration 43:294–298
Greenough A, Yuksel B, Maconochie I (1990) Recurrent respiratory symptoms in the first year of life following preterm delivery. J Perinat Med 18:489–494
Handelman NI, Friday GA, Schwartz HJ (1977) Cromolyn sodium nasal solution in the prophylactic treatment of polleninduced seasonal allergic rhinitis. A tri-city study of efficacy and safety. J Allergy Clin Immunol 59:237–242
Henry RL, Hiller EJ, Milner AD, Hodges IGS, Stokes GM (1984) Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life. Arch Dis Child 59:54–57
Holgate ST (1989) Reflections on the mechanism(s) of action of sodium cromoglycate (Intal) and the role of mast cells in asthma. Respir Med 83 [Suppl]:25S-31S
Miraglia del Giudice M, Capristo A, Maiello N, Apuzzo G (1982) Nebulised sodium cromoglycate for the treatment of asthma in children under 5 years of age. Mod Probl Pediatr 21:122–127
O'Callaghan C, Milner AD, Swarbrick A (1990) Nebulised sodium cromoglycate in infancy: airway protection after deterioration. Arch Dis Child 65:404–406
Patalano F, Ruggieri F (1989) Sodium cromoglycate: a review. Eur Respir J 2 [Suppl 6]:556S-560S
Sibbard B (1980) Extrinsic and intrinsic asthma: influence of classification on family history of asthma and allergic disease. Clin Allergy 10:313–318
Stenmark KR, Eyzaguirre M, Remigio L, Seccombe J, Hensen PM (1985) Recovery of platelet activating factor and leukotrienes from infants with severe bronchopulmonary dysplasia: clinical improvement with cromolyn treatment. Am Rev Respir Dis 131:236A
Yuksel B, Greenough A (1991) Ipratropium bromide in symptomatic preterm infants. Eur J Pediatr 150:854–857
Yuksel B, Greenough A (1991) Effect of nebulised salbutamol in preterm infants during the first year of life. Eur Respir J 4:1088–1092
Yuksel B, Greenough A (1992) Inhaled sodium cromoglycate for preterm children with respiratory symptoms at follow up. Respir Med 86:131–134
Yuksel B, Greenough A, Maconochie I (1990) Effective bronchodilator therapy by a simple spacer device for wheezy premature infants in the first two years of life. Arch Dis Child 65:782–785
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yuksel, B., Greenough, A. The effect of sodium cromoglycate on upper and lower respiratory symptoms in children born prematurely. Eur J Pediatr 152, 615–618 (1993). https://doi.org/10.1007/BF01954094
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01954094